SNTI
SNTI
NASDAQ · Biotechnology

Senti Biosciences Inc

$0.79
-0.09 (-10.36%)
As of Mar 29, 10:54 PM ET ·
Financial Highlights (FY 2025)
Revenue
15.32M
Net Income
933.1K
Gross Margin
52.7%
Profit Margin
6.1%
Rev Growth
-6.3%
D/E Ratio
0.26
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 52.7% 52.7% 52.7%
Operating Margin 7.6% 7.9% 7.6%
Profit Margin 6.1% 8.0% 5.9%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 15.32M 15.18M 16.45M
Gross Profit 8.08M 8.01M 8.68M
Operating Income 1.17M 1.19M 1.25M
Net Income 933.1K 1.21M 962.0K
Gross Margin 52.7% 52.7% 52.7%
Operating Margin 7.6% 7.9% 7.6%
Profit Margin 6.1% 8.0% 5.9%
Rev Growth -6.3% +1.7% +13.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 2.95M 3.21M 3.14M
Total Equity 11.27M 9.87M 10.49M
D/E Ratio 0.26 0.33 0.30
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 2.07M 1.98M 2.22M
Free Cash Flow 922.5K 1.07M 1.04M